Impact of PTGBD on Patients with Acute Complicated Cholecystitis: Consecutive 4,000 Cases of Laparoscopic Cholecystectomy.
- Author:
Jung Hyuk KIM
1
;
Hye Won PARK
;
Mun Su LEE
;
Min Koo LEE
;
Byung Sun CHO
;
Joo Seung PARK
Author Information
1. Department of Surgery, Eulji University Hospital, Daejeon, Korea. jspark@eulji.ac.kr
- Publication Type:Original Article
- Keywords:
Laparoscopic cholecystectomy;
Complicated acute cholecystitis;
Percutaneous transhepatic gallbladder drainage (PTGBD)
- MeSH:
Cholangiopancreatography, Endoscopic Retrograde;
Cholecystectomy;
Cholecystectomy, Laparoscopic;
Cholecystitis;
Cholecystitis, Acute;
Common Bile Duct;
Drainage;
Gallbladder;
Gangrene;
Humans;
Imidazoles;
Inflammation;
Nitro Compounds;
Retrospective Studies
- From:Journal of the Korean Society of Endoscopic & Laparoscopic Surgeons
2011;14(1):12-16
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The aim of this study was to determine the advantage of adequate PTGBD in acute complicated cholecystitis patients. METHODS: We performed a retrospective review of a collected database from September 2001 to July 2008. Acute cholecystitis with gangrene or perforation was defined as acute complicated cholecystitis. A PTGBD was performed for these patients immediately after the diagnosis using US or CT and then a tubogram was performed after 5~7 days. After evaluating the gallbladder (GB) and common bile duct (CBD) with a tubogram, we removed the drainage tube and the patients underwent a LC after readmission. RESULTS: Three hundred seventy four of the 893 patients who were diagnosed with acute cholecystitis underwent PTGBD. While 19 (3.2%) of the total acute cholecystitis patients were converted to open cholecystectomy due to severe inflammation, 14 (3.7%) of the acute complicated patients were converted to open cholecystectomy. In 79 patients, the pre-operative tubogram showed the presence of CBD stone and so ERCP was performed. There were no post-operative deaths. CONCLUSION: PTBGD in acute complicated cholecystitis patients allows the early relief of acute cholecystitis symptoms. This allows sufficient evaluation and treatment for CBD during the PTGBD state. Furthermore, this decreases the mortality and morbidity in the high-risk patients due to sufficient evaluation and management of the underlying critical disease, which allows elective cholecystectomy when the patients is in better condition for surgery. Therefore, PTGBD can be useful for acute complicated cholecystitis.
